Guggenheim lowered the firm’s price target on Neogen (NEOG) to $13 from $15 and keeps a Buy rating on the shares. While a post-integration Neogen “seems to be in view,” a CEO change and uncertain macro backdrop could extend near-term growth choppiness, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue